$2.9 million Australian study AMAZES asthma researchersOctober 16, 2008Researchers in the Hunter region are poised to begin the biggest asthma study of its type in the world. The Asthma and Macrolides: Azithromycin Efficacy and Safety (AMAZES) study will explore a new way of treating inflammations in asthma patients by studying the role of macrolide antibiotics in persistent asthma. Professor Peter Gibson, a Conjoint Professor at the University of Newcastle and Hunter New England Health respiratory specialist, has today secured $2.9 million over five years from the National Health and Medical Research Council (NHMRC) for the study.
"Current asthma medication is focused on treating a particular cell, called an eosinophil," Professor Gibson said. "Increased levels of eosinophils are thought to be responsible for inflammation of the airways. However, almost half of people with asthma symptoms have normal levels of eosinophils and respond poorly to current asthma therapies. "These people suffer from non-eosinophilic asthma, caused by the dysfunction of a primitive arm of the immune system called the innate immune system. "We have previously used macrolide antiobiotics to successfully treat very severe non-eosinophilic patients, significantly reducing their asthmatic inflammation and improving their quality of life." The AMAZES study will determine how effective macrolides are in general for people with asthma, establish the best way to use them, and ensure they are safe to use. More than 2.2 million Australians suffer from asthma, which is a national research priority area. The AMAZES study will begin next year at five centres - Newcastle, Perth, Adelaide And two in Brisbane. Professor Peter Gibson is a Conjoint Professor at the University of Newcastle and Hunter New England Health respiratory specialist. He is Co-Director of the University's Priority Research Centre for Asthma and Respiratory Diseases and conducts research in collaboration with the Hunter Medical Research Institute (HMRI) Viruses, Infections/Immunity, Vaccines and Asthma (VIVA) Research Program. Research Australia | |||||||||||||||||||||
|
Related Asthma Current Events and Asthma News Articles NO help: Nitric oxide monitoring does not help most children with asthma The level of nitric oxide (NO) in an asthmatic's exhaled breath can portend worsening asthma symptoms, and may even signify an imminent attack linked to underlying airway inflammation. Substance abuse adds millions to Medicaid's total health care costs People with substance abuse disorders cost Medicaid hundreds of millions of dollars annually in medical care, suggesting that early interventions for substance abuse could not only improve outcomes but also save substantial amounts of money, according to a comprehensive study that examined records of nearly 150,000 people in six states. Anti-fungal drug offers great benefits to some with severe asthma Some patients with severe asthma who also have allergic sensitivity to certain fungi enjoy great improvements in their quality of life and on other measures after taking an antifungal drug, according to new research from The University of Manchester in England. Fungal pill could provide asthma relief for 150,000 UK sufferers Up to 150,000 people suffering from severe asthma in the UK could benefit from taking antifungal medication already available from pharmacists, new research has found. Mayo Clinic study finds increased risk of pneumococcal disease in asthma patients Mayo Clinic research shows adults with asthma are at increased risk of serious pneumococcal disease caused by Streptococcus pneumoniae, the most common bacteria causing middle ear infections and community acquired pneumonia. Pitt Researchers Create Nontoxic Clean-up Method for Common, Potentially Toxic Nano Materials University of Pittsburgh researchers have developed the first natural, nontoxic method for biodegrading carbon nanotubes, a finding that could help diminish the environmental and health concerns that mar the otherwise bright prospects of the super-strong materials commonly used in products, from electronics to plastics. Study strengthens link between tobacco smoke and behavioral problems in boys with asthma Boys with asthma who are exposed to environmental tobacco smoke have higher degrees of hyperactivity, aggression, depression and other behavioral problems, according to researchers at Cincinnati Children's Hospital Medical Center. Pregnant women with asthma can be more confident about some medicines Women can usually keep using the same asthma drugs they were using before they got pregnant. Budesonide sprays are the best studied and can be regarded as safe. Study shows school-based program enables children and adolescents to better manage chronic disease A new study has found that a school-based asthma education program conducted in the Oakland, California school district was shown to reduce symptoms and increase the number of days that children who suffered from asthma were able to go to school. Pregnant women with asthma can be more confident about some medicines Women can usually keep using the same asthma drugs they were using before they got pregnant. Budesonide sprays are the best studied and can be regarded as safe. More Asthma Current Events and Asthma News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||